arg bpc-157 oral Peptide BPC-157 Delayed - 250mcg -

In studies using tendon fibroblasts in culture (Chang et al., 2011), the introduction of BPC-157 was observed to induce a dose-dependent increase in the phosphorylation of FAK and paxillin, another key focal adhesion protein

Healthletic's BPC-157 meets this need with precision

Pregnancy and lactation are anabolic states that are orchestrated via hormonal and metabolic changes that redirect nutrients to specialized maternal tissues characteristic of reproduction, such as the placenta and mammary glands and, in turn, the developing fetus or infant, respectively (219)

Quick Facts TypePentadecapeptide (15 amino acids) CategoryRecovery / Tissue Repair AdministrationSubcutaneous injection FrequencyOnce or twice daily Typical Dose250 500 mcg/day Cycle Length4 8 weeks Available Sizes5 mg vials Stability30 days after reconstitution Overview What is BPC-157